首页 | 本学科首页   官方微博 | 高级检索  
检索        

米氮平和阿米替林治疗躯体形式障碍对照研究
引用本文:欧阳华,刘玉局.米氮平和阿米替林治疗躯体形式障碍对照研究[J].中国健康心理学杂志,2006,14(5):560-561.
作者姓名:欧阳华  刘玉局
作者单位:中国.江苏省镇江市第四人民医院,212001
摘    要:目的探讨米氮平治疗躯体形式障碍的疗效及安全性。方法对80例躯体形式障碍患者分别用米氮平或阿米替林治疗8周。采用汉密尔顿抑郁量表(HAMD)及副反应量表(TESS)评定药物疗效及不良反应。结果米氮平与阿米替林疗效相当,起效快,米氮不良反应轻微。结论米氮平治疗躯体形式障碍疗效肯定,不良反应小。

关 键 词:米氮平  阿米替林  躯体形式障碍  副反应量表
收稿时间:2006-03-15
修稿时间:2006-03-15

Comparison of Mirtazapine and Amitriptyline in the Treatment of Somatoform Disorders
Ouyang Hua,Liu Yuju.Comparison of Mirtazapine and Amitriptyline in the Treatment of Somatoform Disorders[J].china journal of health psychology,2006,14(5):560-561.
Authors:Ouyang Hua  Liu Yuju
Institution:Zhen- jiang No. 4 Hospital, Zhenjiang 212001, P.R. China
Abstract:Objective To investigate the effectiveness and the safeness of mirtazapine and amitriptyline in the treatment of somatoform disorders. Methods Eighty patients with somatoform disorders were divided into two groups and were treat with mirtazapine and amitriptyline respectively for eight weeks. All patients were assessed with HAMD and TESS to estimate the efficacy and side effects of the drugs. Results Compared with amitriptyline, mirtazapine was shown to have almost the same effectiveness, but quicker response and milder side effects. Conclusion Mirtazapine has positive efficacy and less side effect in the treatment of somatoform disorder.
Keywords:Mirtazapine  Amitriptyline  Somatoform disoder  TESS
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号